With its trailblazing analysis technology and digitalization of sample profiles, CETICS ensures a drastic simplification of in-vitro diagnostics (IVD).
Cost-effective, high-precision infrared spectra are obtained with the patented AquaSpec mid-infrared spectroscopy from biological fluid samples such as blood serum, cerebrospinal fluid, and cell culture supernatant. These spectra contain complex information on the sample components and their concentrations. Each spectrum provides a corresponding snapshot of the individual metabolome and can be digitally saved.
In contrast to conventional diagnostic methods, electronic evaluation algorithms can now quantitatively determine many blood values from a single spectrum. Disease states can be diagnosed in the spectrum with characteristic patterns – also for illnesses not previously diagnosable in vitro. Moreover, it is possible to monitor concentrations of drug substances in the course of therapy individually, rapidly, and cost-effectively.
CETICS provides the market with completely new diagnostic possibilities and simultaneously ensures significant cost reductions and simplifications of routine diagnostics.